Skip to content

Arrowhead Pharmaceuticals

US · ARWR #1569 by market cap Listed 1970
41.37 -2.28 -5.22%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. Its drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Founded
1989
CEO
Dr. Christopher Anzalone,PhD
Employees
711
Headquarters
Pasadena, California, United States of America
Fiscal year end
09-30
Website
arrowheadpharma.com

Company profile

Exchange
US
Symbol
ARWR
Market-cap rank
#1569
Listing date
1970-01-01
Market cap
5.85B
Float cap
5.08B
Shares out
141.37M
Float shares
122.91M

Sectors & themes

Weight Loss Drugs Biotechnology Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Arrowhead Pharmaceuticals discussion 0 comments

Add a comment